Network origin in Catherine Mathis first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
32
| Public Company | Biotechnology | 32 |
| Subsidiary | Pharmaceuticals: Major | 4 | |
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Voisin Consulting, Inc.
 Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Voisin Consulting, Inc. provides product development consulting services. It guides biotechnology, pharmaceutical and medical technology manufacturers throughout product development and commercialization. The company was founded by Emanuelle M. Viosin in 1997 and is headquartered in Cambridge, MA.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Catherine Mathis via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| IPSEN | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Stanford University | College/University | Graduate Degree Masters Business Admin | |
| NICOX SA | Pharmaceuticals: Major | Director/Board Member Chairman Public Communications Contact | |
| STALLERGENES | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Sales & Marketing | |
| BIOMÉRIEUX | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Public Communications Contact Sales & Marketing Corporate Officer/Principal | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
TSGH SAS
 TSGH SAS Financial ConglomeratesFinance TSGH SAS operates as an investment holding company. The company is headquartered in Lyon, France. | Financial Conglomerates | Chief Executive Officer Chairman | |
Avesthagen Ltd.
 Avesthagen Ltd. Miscellaneous Commercial ServicesCommercial Services Avesthagen Ltd. provides personalized healthcare through convergence of food, pharma and population genetics. It offers genome analysis, transcriptome analysis, metabolome analysis and lead optimization, and recombinant protein expression services, as well as engages in the generation of stable mammalian cell lines over-expressing a recombinant protein, development of product specific bioassays, and design of novel animal component free production media. The company was founded by Villoo Morwala Zareer Patell on April 20, 1998 and is headquartered in Bangalore, India. | Miscellaneous Commercial Services | Director/Board Member | |
| INSEAD | College/University | Masters Business Admin Graduate Degree | |
| INNATE PHARMA | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Biotechnology | Founder Chief Executive Officer | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Graduate Degree Graduate Degree | |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| EM Lyon Business School | College/University | Graduate Degree Graduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| University of Strasbourg | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| University of Nice Sophia Antipolis | College/University | Doctorate Degree Graduate Degree | |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Biotechnology | President Director of Finance/CFO Director of Finance/CFO | |
| Pasteur Mérieux Connaught | Chief Tech/Sci/R&D Officer Comptroller/Controller/Auditor | ||
Alsace BioValley Association
 Alsace BioValley Association Medical/Nursing ServicesHealth Services Alsace BioValley Association operates as a health innovation center. The private company is based in Illkirch, France. | Medical/Nursing Services | President Chairman | |
Advanced BioScience Laboratories, Inc.
 Advanced BioScience Laboratories, Inc. Medical/Nursing ServicesHealth Services Advanced BioScience Laboratories, Inc. provides contract manufacturing and laboratory research services to advance leading vaccines and therapies from clinical development to the commercial market. It focuses on the development of therapeutics, vaccines, and other biologic products. The company was founded in 1961 and is headquartered in Rockville, MD. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| University of Lyon | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Compagnie Merieux Alliance SAS
 Compagnie Merieux Alliance SAS Investment Trusts/Mutual FundsMiscellaneous Compagnie Mérieux Alliance SAS owns shares and interests in firms that manufactures, sells, and distributes medicines and other pharmaceutical products. The company is headquartered in Lyon, France. | Investment Trusts/Mutual Funds | Director of Finance/CFO | |
| ADOCIA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Silliker Group Corp. SARL
 Silliker Group Corp. SARL Miscellaneous Commercial ServicesCommercial Services Silliker Group Corp. SARL operates as holding firm with interest in food testing and consulting network. The company was founded in 2008 and is headquartered in Tassin-la-Demi-Lune, France | Miscellaneous Commercial Services | Director/Board Member | |
bioMERIEUX Benelux SANV
 bioMERIEUX Benelux SANV Medical SpecialtiesHealth Technology bioMERIEUX Benelux SANV is specialized in the field of in vitro diagnostics for medical and industrial applications. The group designs, develops, manufactures and markets systems used in clinical applications (diagnosis of infectious diseases based on the analysis of biological samples) and industrial applications (the analysis of industrial or environmental samples to determine its microbiological quality). The company was founded in 1979 and is headquartered in Bruxelles, Belgium | Medical Specialties | Director/Board Member Director/Board Member | |
Institut Mérieux SA
 Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Corporate Secretary | |
Association Lyon Place Financière
 Association Lyon Place Financière Miscellaneous Commercial ServicesCommercial Services Association Lyon Place Financière et Tertiaire operates as a business consortium, with interest in the promotion of regional financial development. Its advocacies cover the monitoring of competitivenes, risk, equity, shareholder relations, investment, and transparency. The company was founded by Roger Michaux, Raymond Barre, Régis Lagrevol, and Etienne Subra in 1986 and is headquartered in Lyon, France. | Miscellaneous Commercial Services | Director/Board Member | |
| SENSORION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Synergie Lyon Cancer
 Synergie Lyon Cancer Miscellaneous Commercial ServicesCommercial Services Synergie Lyon Cancer provides health care services. It focuses on research efforts on cancer escape, apoptosis and senescence and Immune surveillance. The company was founded in 2007 and is headquartered in Lyon, France. | Miscellaneous Commercial Services | Director/Board Member President | |
| Transgene, Inc. | Director/Board Member Director/Board Member | ||
| Laboratoire Pierre Fabre Oncologie | Director/Board Member Chief Executive Officer | ||
Lyon Pôle Bourse
 Lyon Pôle Bourse Financial ConglomeratesFinance Lyon Pôle Bourse engages in the provision of regional economy development services. The company was founded in 2009 and is headquartered in Lyon, France. | Financial Conglomerates | Director/Board Member | |
Platine Pharma Services SAS
 Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Based in Lyon within the Center of excellence in Infectious Diseases, Platine Pharma Services is an essential source of immune information for scientists and clinicians. From protocol support to regulatory reports, the company designs, performs and interprets complex molecular and cellular assays. Platine actively supports the development of in-vitro diagnostic, cosmetic and therapeutic product candidates, highlighting key markers and features in both normal and pathological conditions, and guiding decisions at each development stage. Using state-of-the-art technologies such as multi-parametric flow cytometry, Singulex, Luminex, Mesoscale Discovery, ELISpot or ELISA, Platine Pharma Services offers a fit-for-purpose approach to its customers and partners. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
 Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. | Director/Board Member Director/Board Member | ||
| GENEURO SA | Biotechnology | Director/Board Member Director/Board Member | |
Bio -harma & Life-Sciences Consulting SRL
 Bio -harma & Life-Sciences Consulting SRL Miscellaneous Commercial ServicesCommercial Services Bio-harma & Life-Sciences Consulting SRL is a biotechnology research and development company based in Paris, France. Bio-harma & Life-Sciences Consulting SRL provides biotechnology research and development services. The French company was founded by David Liens and he has been the CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer | |
EG 427
 EG 427 Miscellaneous Commercial ServicesCommercial Services EG 427 is a French biotechnology company that specializes in gene therapy. The location of the company is unknown. The company was founded by Alberto Epstein, François Giuliano, and Philippe O. Chambon, with Philippe O. Chambon serving as CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
| PHAXIAM THERAPEUTICS S.A. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Mérieux NutriSciences Corp.
 Mérieux NutriSciences Corp. Miscellaneous Commercial ServicesCommercial Services Mérieux NutriSciences Corp. engages in the provision of scientific service solutions to food industries. It offers offers analytical and product development solutions to prevent health risks related to food and more generally to the use of everyday consumer products. It also offers digital solutions as part of its dedicated business The company was founded by John H. Silliker and Charles M?rieux in 1967 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member |
Statistics
International
| France | 36 |
| United States | 8 |
| China | 3 |
| Germany | 2 |
| India | 2 |
Sectoral
| Health Technology | 23 |
| Consumer Services | 10 |
| Commercial Services | 10 |
| Health Services | 4 |
| Finance | 3 |
Operational
| Director/Board Member | 169 |
| Corporate Officer/Principal | 60 |
| Chairman | 51 |
| Chief Executive Officer | 38 |
| Independent Dir/Board Member | 34 |
Most connected contacts
| Insiders | |
|---|---|
| Jean-Luc Bélingard | 40 |
| Benoît Habert | 34 |
| Bernard Gilly | 32 |
| Jean Bizzari | 24 |
| Philippe Archinard | 24 |
| Stéphane Boissel | 24 |
| Dominique Takizawa | 23 |
| Bernard Davitian | 19 |
| Jean-François Labbé | 18 |
| Margaret Liu | 15 |
| Michel Dubois | 12 |
| Georges Hibon | 10 |
| Hemanshu Shah | 10 |
| Pascal Neuville | 9 |
| Pierre-Patrick Hurteloup | 9 |
- Stock Market
- Insiders
- Catherine Mathis
- Company connections
